Dose: 2 mg
Single Dose: 2 (2)
Frequency: 24 hourly
Route: PO
Instructions: May be given upto 4-6 mg/day if needed

. It is of Synthetic origin and belongs to Dihydropyridine. . The Molecular Weight of Lacidipine is 455.50.

Lacidipine is contraindicated in conditions like Hypersensitivity,Aortic stenosis,Left ventricular dysfunction.

The severe or irreversible adverse effects of Lacidipine, which give rise to further complications include Hypotension, Hypotension, Exacerbated angina, Gingival hypertrophy.The signs and symptoms that are produced after the acute overdosage of Lacidipine include Tachycardia, Prolonged peripheral vasodilation.The symptomatic adverse reactions produced by Lacidipine are more or less tolerable and if they become severe, they can be treated symptomatically, these include Dizziness, Headache, Dyspnea, Palpitation, Flushing, Polyuria, Muscle cramps, Paresthesias, Ankle edema, Hypotensive crisis, Sexual impotence, Cold legs, dizziness.

Lacidipine is primarily indicated in conditions like Hypertension.

Lacidipine is known to interact with other drugs, the details of drug interactions is as follows:DrugDetailsSeverityOnsetManagementAtenololEnhanced hypotensive effects when beta-blockers (e.g Atenolol) given with calcium-channel blockers (e.g Lacidipine).Cimetidine (HCl)DigoxinPropranolol (HCl) These interactions are sometimes beneficial and sometimes may pose threats to life. Always consult your physician for the change of dose regimen or an alternative drug of choice that may strictly be required.

Drug should not be given to Paediatrics, Pregnant Mothers, and Neonates.If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.

Store Below 30°C. Protect from Sunlight.

Lacidipine should be used with caution in patients with kidney or liver disease. Consider decrease in dose of calcium channel blockers and monitor drug response in cirrhosis patients. It should be used with caution in the patient with hypotension. It should not be used in the cardiogenic shocks, recent Myocardial Infarction and in acute unstable angina. Sudden withdrawal of lacidipine might be associated with an exacerbation of angina. The drug should be discontinued in the patient who experience ischaemic pain following its administration.